The world needs new antibiotics to overcome the ever-increasing resistance of disease-causing bacteria – but it doesn’t need the side effect that comes with some of the most powerful ones now available: hearing loss. Today, researchers report they have developed a new approach to designing antibiotics that kill even “superbugs” but spare the delicate sensory cells of the inner ear.

AHMEDABAD: A city-based pharmaceutical research center has developed a capsule using novel floating technology which will allow better absorption of TB drug and thus help people fight TB better.

The director of the Pasteur Institute says Iran has succeeded in producing high quality tuberculosis vaccine in a modern way, Iran's Mehr News Agency (MNA) reported.

HIV & AIDS treatment in practice (HATIP) is a regular email newsletter for healthcare workers and community-based organisations on HIV treatment in resource-limited settings.

WHO is working with countries to identify opportunities for expansion of treatment in line with its 2010 guidelines, which recommended treatment for all people living with HIV with CD4 cell counts below 350, all infants below the age of 2, and for everyone with TB and HIV or hepatitis B and HIV coinfection.

Russia currently ranks third by the number of multidrug-resistant TB cases worldwide after China and India, countries with vastly larger populations.

ACTION has produced a short film to demonstrate the effectiveness of GeneXpert testing in combatting the spread of tuberculosis in resource-limited settings.

In a step that is likely to unnerve global drugmakers, China has overhauled parts of its intellectual property law to allow its domestic pharmaceutical industry to make low-cost versions of medicines under patent protection, Reuters reports. The amended Chinese patent law allows Beijing to issue compulsory licenses to eligible companies to produce generic versions of patented drugs during state emergencies, unusual circumstances or in the public interest.

Europe's Innovative Medicines Initiative (IMI) has launched seven new projects, costing a combined 215 million euros, which will take on some of the biggest challenges in healthcare research.

Benedict Xaba, Minister of Health of Swaziland, has said that new partnerships must be formed in order to achieve the goals set out in a forthcoming declaration on TB and Mining in Southern Africa.